[ad_1]
Globe Biotech, a subsidiary of Globe Pharmaceuticals Group of Companies Limited, invented the world’s first D614G variant of the ‘Bancovid’ coronavirus mRNA-based vaccine, according to the US Medical Journal Bioarchive. They have also published a report on their website.
In this regard, the manager and head of Quality and Regulatory Operations of Globe Biotech Limited and member of the research team for the discovery of vaccines, Dr. Mohammad Mohiuddin Daily our online time“The latest advances in our research have been published today in an international medical journal,” said K.
He added: “Next week there will be a press conference on the completion of the pre-clinical trial controlled by the vaccine and the preparation of the clinical trial. The press conference will be held at the company’s corporate office in Tejgaon. Details will be presented at the press conference.
Globe Biotech Limited, a pharmaceutical company, has demanded the discovery of a vaccine for Kovid-19 disease for the first time in the country. Globe Biotech Limited began its journey in 2015 with the creation of state-of-the-art laboratories for the production of biological products, novel drugs and biosimilars for the treatment of cancer, arthritis, anemia, hypertension, autoimmune diseases and other incurable diseases.
In addition to research on ‘Globe Biotech Limited’ for national and international needs, they have also started researching on the discovery of Covid-19 ‘identification kits, vaccines and drugs’.
[ad_2]
